SCHEMBL4699803

SCHEMBL4699803

CCCCCCc1nc(-c2cccc(NC(=N)c3cccs3)c2)c[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.42
LMNA P02545 5/20 0.41
TP53 P04637 3/20 0.41
KDM4E B2RXH2 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
POLB P06746 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
RAB9A P51151 2/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.38
GAA P10253 2/20 0.38
GLA P06280 1/20 0.38
NPC1 O15118 1/20 0.38
CLK1 P49759 1/20 0.38
HDAC1 Q13547 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5642754 0.99 MAPT (0.42) MAPTLMNATP53KDM4ESMN1; SMN2
SCHEMBL5643301 0.86 MAPT (0.43) MAPTLMNAKDM4ESMN1; SMN2POLB
SCHEMBL4703800 0.84 MAPT (0.44) MAPTLMNAKDM4ESMN1; SMN2POLB
SCHEMBL4699269 0.83 MAPT (0.38) MAPTLMNAKDM4ESMN1; SMN2POLB
SCHEMBL4698973 0.83 MAPT (0.41) MAPTLMNATP53KDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL5643385 0.83 MAPT (0.43) MAPTLMNAKDM4ESMN1; SMN2POLB
Hydrochloric Acid SCHEMBL5643980 0.83 MAPT (0.38) MAPTLMNAKDM4ESMN1; SMN2POLB
Hydrochloric Acid SCHEMBL5644627 0.82 MAPT (0.41) MAPTLMNATP53KDM4ESMN1; SMN2
SCHEMBL4699977 0.81 MAPT (0.39) MAPTLMNAKDM4ESMN1; SMN2POLB
Hydrochloric Acid SCHEMBL5645088 0.80 MAPT (0.39) MAPTLMNAKDM4ESMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1527068-B1 NOVEL ARYLIMIDAZOLE DERIVATIVES, THEIR USE AS NO-SYNTASE INHIBITORS AND AS MODULATORS OF SODIUM CHANNELS SOD CONSEILS RECH APPLIC (FR) 2008-01-09 EP claimed
US-7192975-B2 Arylimidazole derivatives, preparation and therapeutic used thereof SOCIETE DE CONSEILS DE RECHERCHES ET D''APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2007-03-20 US claimed
EP-1527068-A2 NOVEL ARYLIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USES THEREOF SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2005-05-04 EP claimed
WO-2004011402-A2 NOVEL ARYLIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USES THEREOF SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2004-02-05 WO claimed
EP-1527068-B1 NOVEL ARYLIMIDAZOLE DERIVATIVES, THEIR USE AS NO-SYNTASE INHIBITORS AND AS MODULATORS OF SODIUM CHANNELS SOD CONSEILS RECH APPLIC (FR) 2008-01-09 EP disclosed
US-7192975-B2 Arylimidazole derivatives, preparation and therapeutic used thereof SOCIETE DE CONSEILS DE RECHERCHES ET D''APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2007-03-20 US disclosed
EP-1527068-A2 NOVEL ARYLIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USES THEREOF SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2005-05-04 EP disclosed
WO-2004011402-A2 NOVEL ARYLIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USES THEREOF SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2004-02-05 WO disclosed